Since the November 2011 announcement, there has been tremendous interest in the IRB approved stem cell trial for multiple sclerosis. Due to the overwhelming response, the IMSMP and MSRCNY hope to expand the study to include 40 participants instead of the initially approved 20. The first six participants have already been selected, but therapy will not be initiated until funding through grants and private donors has been obtained. There are certain inclusion and exclusion criteria that must be satisfied to be eligible for the trial. If you are interested in participating in the study, all of these criteria will be addressed with the physician at your next office visit. For more information please contact Deirdre Dulak and Daniel Koffler at (646) 557-3860 and (646) 557-3852.